cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
1.200
+0.569 (90.17%)
At close: Dec 12, 2025, 4:00 PM EST
1.100
-0.100 (-8.33%)
After-hours: Dec 12, 2025, 8:00 PM EST
cbdMD Market Cap
cbdMD has a market cap or net worth of $10.7 million as of December 12, 2025. Its market cap has increased by 448.51% in one year.
Market Cap
10.70M
Enterprise Value
10.60M
1-Year Change
448.51%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since December 21, 2018, cbdMD's market cap has decreased from $28.33M to $10.70M, a decrease of -62.25%. That is a compound annual growth rate of -13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 10.70M | 414.91% |
| Dec 31, 2024 | 2.08M | -32.55% |
| Dec 29, 2023 | 3.08M | -77.64% |
| Dec 30, 2022 | 13.77M | -78.11% |
| Dec 31, 2021 | 62.93M | -59.08% |
| Dec 31, 2020 | 153.79M | 145.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |